RE:RE:RE:RE:RE:RE:'' To good to be true''@Infinity, I do recognize the time frame. I also know that with the posibility of an AA, there is our native revenue stream. BTD, then more long-term data, then possible AA.
I wouldn't want to jump into a loan without a confirmed revenue stream. I wouldn't make a JV offer without longer-term confirmed data either. I'm convinced there have been shallow, drive-by offers and I'm sure management had to sign an NDA. So, they couldn't disclose any terms, conditions or monitary offers.
TLT isn't going to get a JV until the data is right and then (1 - just 1 to start the bidding war) BigPharma gets desperate. I wouldn't negotiate a JV, without the right of first refusal, or include onerous conditions from which to keep a bidding war from starting. Those conditions by themselves would keep me from entering a JV - even for a piece of the company. Unless TLT is willing to "license" a small regional territory.
There are a few large BigPharma companies that would be a good strategic fit, and a few of their competitors that would love to leap-ahead of the obvious partners. The question is "Who's willing to start the bidding?"
We still have time, and BigPharma can make this JV/License agreement happen quickly. Until the conditions and terms are "right," I trust RDM. He has too much invested in this for a bad deal. And to our benefit, a bad deal for the company is a bad deal for him and us.
Thank you.
Good Luck To All, BK.